Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
M Hashemi, MS Moosavi, HM Abed, M Dehghani… - Pharmacological …, 2022 - Elsevier
Initiation and development of cancer depend on multiple factors that mutations in genes and
epigenetic level can be considered as important drivers. Epigenetic factors include a large …
epigenetic level can be considered as important drivers. Epigenetic factors include a large …
[HTML][HTML] H19 lncRNA: roles in tumorigenesis
H19 is a long non-coding RNA [lncRNA] which was firstly described as an oncofetal
transcript. The imprinted gene is normally expressed from the maternal allele. However, this …
transcript. The imprinted gene is normally expressed from the maternal allele. However, this …
Deep-belief network for predicting potential miRNA-disease associations
MicroRNA (miRNA) plays an important role in the occurrence, development, diagnosis and
treatment of diseases. More and more researchers begin to pay attention to the relationship …
treatment of diseases. More and more researchers begin to pay attention to the relationship …
[HTML][HTML] Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Y Liu, W Ding, J Wang, X Ao, J Xue - Frontiers in oncology, 2023 - frontiersin.org
Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth,
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …
and early metastasis. The clinical outcomes of LC patients are generally poor due to the …
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
M Garg, MK Shanmugam, V Bhardwaj… - Medicinal research …, 2021 - Wiley Online Library
Signal transducer and activator of transcription 3 (STAT3) is one of the crucial transcription
factors, responsible for regulating cellular proliferation, cellular differentiation, migration …
factors, responsible for regulating cellular proliferation, cellular differentiation, migration …
[HTML][HTML] A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer
W Wang, W Lou, B Ding, B Yang, H Lu, Q Kong… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Background: Recently, increasing evidence has uncovered the roles of mRNA-miRNA-
lncRNA network in multiple human cancers. However, a systematic mRNA-miRNA-lncRNA …
lncRNA network in multiple human cancers. However, a systematic mRNA-miRNA-lncRNA …
[HTML][HTML] Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
Y Lei, W Guo, B Chen, L Chen… - Oncology …, 2018 - spandidos-publications.com
Currently, resistance to tyrosine kinase inhibitors, such as gefitinib, has become one major
obstacle for improving the clinical outcome of patients with metastatic and advanced‑stage …
obstacle for improving the clinical outcome of patients with metastatic and advanced‑stage …
[HTML][HTML] Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
Z Chen, Q Chen, Z Cheng, J Gu, W Feng, T Lei… - Cell Death & …, 2020 - nature.com
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such
as gefitinib, has greatly affected clinical outcomes in non-small cell lung cancer (NSCLC) …
as gefitinib, has greatly affected clinical outcomes in non-small cell lung cancer (NSCLC) …
Noncoding RNAs in vascular diseases
N Jaé, S Dimmeler - Circulation research, 2020 - Am Heart Assoc
The advent of deep sequencing technologies led to the identification of a considerable
amount of noncoding RNA transcripts, which are increasingly recognized for their functions …
amount of noncoding RNA transcripts, which are increasingly recognized for their functions …
[HTML][HTML] Epigenetic alterations and inflammation as emerging use for the advancement of treatment in non-small cell lung cancer
Lung cancer remains one of the most common malignancies in the world. Nowadays, the
most common lung cancer is non-small cell lung cancer (NSCLC), namely …
most common lung cancer is non-small cell lung cancer (NSCLC), namely …